查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386413

肺部藥物輸送市場報告：2030 年趨勢、預測與競爭分析

Pulmonary Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

肺部藥物輸送的趨勢和預測

預計到 2030 年，全球肺部藥物輸送市場將達到 681 億美元，2024 年至 2030 年年複合成長率為 2.5%。這個市場的主要促進因素是呼吸系統疾病盛行率的上升、人們對肺部藥物輸送益處的認知不斷提高以及對居家醫療服務的需求不斷增加。全球肺部藥物輸送市場的未來被認為是充滿希望的，醫院/診所市場和居家醫療市場都有商機。

肺部藥物輸送市場洞察

Lucintel 預測，由於呼吸系統疾病的盛行率不斷增加以及慢性慢性阻塞性肺病肺病治療的有利報銷政策，慢性阻塞性慢性阻塞性肺病(COPD) 在預測期內仍將是最大的細分市場。

在這個市場中，隨著全球醫院藥局數量的不斷增加，醫院和診所將繼續成為一個重要的細分市場。

由於其先進的醫療保健系統，北美將繼續成為最大的地區，為患者提供最新的肺部藥物輸送設備和治療方法。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪個產業將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球肺部藥物輸送市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球肺部藥物輸送市場趨勢（2018-2023）與預測（2024-2030）
  • 全球肺部藥物輸送市場（按應用）
    • 氣喘
    • 慢性阻塞性肺病
    • 過敏性鼻炎
    • 囊腫纖維化
    • 其他
  • 按最終用途分類的全球肺部藥物輸送市場
    • 醫院和診所
    • 居家照護
  • 按配銷通路的全球肺部藥物輸送市場
    • 醫院藥房
    • 零售藥房
    • 電子商務

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球肺部藥物輸送市場區域分佈
  • 北美肺部藥物輸送市場
  • 歐洲肺部藥物輸送市場
  • 亞太肺部藥物輸送市場
  • 其他區域性肺部藥物輸送市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球肺部藥物輸送市場成長機會（按應用）
    • 全球肺部藥物輸送市場最終用途的成長機會
    • 按配銷通路的全球肺部藥物輸送市場成長機會
    • 按地區分類的全球肺部藥物輸送市場成長機會
  • 全球肺部藥物輸送市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球肺部藥物輸送市場的產能
    • 全球肺部藥物輸送市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • GlaxoSmithKline
  • 3M Company
  • Koninklijke Philips
  • AstraZeneca
  • Boehringer Ingelheim
簡介目錄

Pulmonary Drug Delivery Trends and Forecast

The future of the global pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets. The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030 with a CAGR of 2.5% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.

A more than 150-page report is developed to help in your business decisions.

Pulmonary Drug Delivery by Segment

The study includes a forecast for the global pulmonary drug delivery by application, end use, distribution channel, and region.

Pulmonary Drug Delivery Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Allergic Rhinitis
  • Cystic Fibrosis
  • Others

Pulmonary Drug Delivery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Home Care

Pulmonary Drug Delivery Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Pulmonary Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pulmonary Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pulmonary drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pulmonary drug delivery companies profiled in this report include-

  • Glaxosmithkline
  • 3M Company
  • Koninklijke Philips
  • Astrazeneca
  • Boehringer Ingelheim

Pulmonary Drug Delivery Market Insights

Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.

Within this market, hospitals & clinics will remain the larger segment due to growing number of hospital pharmacies across the globe.

North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.

Features of the Global Pulmonary Drug Delivery Market

Market Size Estimates: Pulmonary drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pulmonary drug delivery market size by application, end use, distribution channel, and region in terms of value ($B).

Regional Analysis: Pulmonary drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, end uses, distribution channels, and regions for the pulmonary drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pulmonary drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pulmonary drug delivery market size?

Answer: The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030.

Q.2 What is the growth forecast for pulmonary drug delivery market?

Answer: The global pulmonary drug delivery market is expected to grow with a CAGR of 2.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pulmonary drug delivery market?

Answer: The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.

Q4. What are the major segments for pulmonary drug delivery market?

Answer: The future of the pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets.

Q5. Who are the key pulmonary drug delivery market companies?

Answer: Some of the key pulmonary drug delivery companies are as follows:

  • Glaxosmithkline
  • 3M Company
  • Koninklijke Philips
  • Astrazeneca
  • Boehringer Ingelheim

Q6. Which pulmonary drug delivery market segment will be the largest in future?

Answer: Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.

Q7. In pulmonary drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pulmonary drug delivery market by application (asthma, chronic obstructive pulmonary disease, allergic rhinitis, cystic fibrosis, and others), end use (hospitals & clinics and home care), distribution channel (hospital pharmacies, retail pharmacies, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pulmonary Drug Delivery Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pulmonary Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pulmonary Drug Delivery Market by Application
    • 3.3.1: Asthma
    • 3.3.2: Chronic Obstructive Pulmonary Disease
    • 3.3.3: Allergic Rhinitis
    • 3.3.4: Cystic Fibrosis
    • 3.3.5: Others
  • 3.4: Global Pulmonary Drug Delivery Market by End Use
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Home Care
  • 3.5: Global Pulmonary Drug Delivery Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Retail Pharmacies
    • 3.5.3: E-commerce

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pulmonary Drug Delivery Market by Region
  • 4.2: North American Pulmonary Drug Delivery Market
    • 4.2.2: North American Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
  • 4.3: European Pulmonary Drug Delivery Market
    • 4.3.1: European Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
    • 4.3.2: European Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
  • 4.4: APAC Pulmonary Drug Delivery Market
    • 4.4.1: APAC Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
    • 4.4.2: APAC Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
  • 4.5: ROW Pulmonary Drug Delivery Market
    • 4.5.1: ROW Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
    • 4.5.2: ROW Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Application
    • 6.1.2: Growth Opportunities for the Global Pulmonary Drug Delivery Market by End Use
    • 6.1.3: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Region
  • 6.2: Emerging Trends in the Global Pulmonary Drug Delivery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pulmonary Drug Delivery Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pulmonary Drug Delivery Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: 3M Company
  • 7.3: Koninklijke Philips
  • 7.4: AstraZeneca
  • 7.5: Boehringer Ingelheim